Leading e-cigarette researcher Professor Riccardo Polosa visiting Australia

Posted by DrMendelsohn on 22 March, 2017

Professor Riccardo Polosa cropped.jpgRiccardo Polosa is Full Professor of Internal Medicine at the University of Catania with specialist role as a Respiratory Physician, Clinical Immunologist, Allergist and Rheumatologist.

Professor Polosa is visiting Australia to attend the Annual Scientific Meetings of the Australian and New Zealand Society of Respiratory Science and the Thoracic Society of Australia and New Zealand.

Professor Polosa is Director of the Institute of Internal and Emergency Medicine at the main teaching hospital of the University of Catania, where he coordinates a large staff of senior physicians, young residents, nurses and administrators.

He is also the Director of the School of Specialization in Rheumatology and the Founder and Director of the Centre for Tobacco Research at the same University, where contracted research staff conducts high profile clinical and behavioural research. 

He acts as Scientific Advisor for LIAF (the Italian Antismoking League), and has been recently elected Convenor for the Working Group on “Requirements and test methods for emissions of electronic cigarettes”, within the European Committee for Standardization (CEN/TC 437).  He has been chairing meetings of this Working Group in Europe before leaving for Australia.

The focus of Professor Polosa’s academic research has been centred upon the investigation of mechanisms of inflammation, biomarkers of disease activity, and novel drug target discovery in the areas of respiratory medicine and clinical immunology.

Over the last 10 years, his main research interest has progressively shifted to tobacco-related diseases, smoking prevention and cessation, tobacco harm reduction and e-vapour products. 

More specifically, he has been involved in the behavioural, clinical, physiological and toxicological evaluation of e-cigarettes for over 6 years. He was principal investigator of the first randomised control trial in the world about effectiveness and tolerability of e-cigarettes (the ECLAT study).

Professor Polosa has been identified as the most prolific author in the field of e-cigarettes, according to a recent bibliometric research (H. Zyoud et al., BMC Public Health 2014, 14:667).

Click here to see some of Professor Polosa's research on e-cigarettes.

blog comments powered by Disqus

Recent Posts

Show all posts